medical device clinical trial intelligence

Validation and Usability Study of Intermittent Electrical Simulation (Prelivia) IES in the Management of Pressure Injuries Stage 1 and Stage 2

Validation and Usability Study of Intermittent Electrical Simulation (Prelivia) IES in the Management of Pressure Injuries Stage 1 and Stage 2 is a NA clinical asset sponsored by University of British Columbia in Pressure Injury. SEO and diligence focus: Prelivia, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

Effect Of Simultaneous Working Length Control During Root Canal Preparation Versus Electronic Apex Locator On Postoperative Pain in Teeth With Symptomatic Irreversible Pulpitis (a Randomized Clinical Trial)

Effect Of Simultaneous Working Length Control During Root Canal Preparation Versus Electronic Apex Locator On Postoperative Pain in Teeth With Symptomatic Irreversible Pulpitis (a Randomized Clinical Trial) is a NA clinical asset sponsored by Cairo University in Postoperative Pain. SEO and diligence focus: simultaneous working length control using E-CONNECT S, separate length determination and root canal preparation using Root ZX apex locator., endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

Home-based Transcranial Direct Current Stimulation (tDCS) for Pain Management in Persons With Alzheimer's Disease and Related Dementias

Home-based Transcranial Direct Current Stimulation (tDCS) for Pain Management in Persons With Alzheimer's Disease and Related Dementias is a NA clinical asset sponsored by Florida State University in Alzheimer's Disease and Related Dementias. SEO and diligence focus: Active tDCS, Sham tDCS, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases

Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases is a NA clinical asset sponsored by Kuopio University Hospital in Alzheimer Disease, Frontotemporal Dementia, Dementia With Lewy Bodies. SEO and diligence focus: Gamma tACS (40 Hz) over the superior parietal cortex, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

Initiation of Long-term Home Non-invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Using the iVAPS Mode During a Daytime Trial

Initiation of Long-term Home Non-invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Using the iVAPS Mode During a Daytime Trial is a NA clinical asset sponsored by Marta Kaminska in Amyotrophic Lateral Sclerosis (ALS). SEO and diligence focus: Non-invasive home ventilation, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

Evaluation of the Impact of a Wearable Noninvasive Positive Pressure Ventilation Device on Physical Activity and Quality of Life in Patients With COPD

Evaluation of the Impact of a Wearable Noninvasive Positive Pressure Ventilation Device on Physical Activity and Quality of Life in Patients With COPD is a NA clinical asset sponsored by Icadom in Non-Invasive Ventilation. SEO and diligence focus: Non-Invasive Ventilation, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

CAvent-Ventilation During Advanced Cardiopulmonary Resuscitation in Out-of-hospital Cardiac Arrest- an Observational Study

CAvent-Ventilation During Advanced Cardiopulmonary Resuscitation in Out-of-hospital Cardiac Arrest- an Observational Study is a registry-stage clinical asset sponsored by Uppsala University in Out-of-Hospital Cardiac Arrest, Pulmonary Ventilation. SEO and diligence focus: Fluxmed GrH portable pneumotachograph, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Mellitus Patients Not Achieving Glycemic Targets on Basal Insulin With/Without Anti-Hyperglycemic Agents

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Mellitus Patients Not Achieving Glycemic Targets on Basal Insulin With/Without Anti-Hyperglycemic Agents is a NA clinical asset sponsored by Calibra Medical, Inc. in Diabetes Mellitus, Type 2. SEO and diligence focus: Bolus Insulin Patch (Calibra Finesse), Insulin Pen (Novo-Nordisk FlexPen®), endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic Antimalarials

Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic Antimalarials is a NA clinical asset sponsored by Fondation Ophtalmologique Adolphe de Rothschild in Toxicity, Drug, Maculopathy. SEO and diligence focus: spectral domain optical coherence tomography C-scan and multifocal electroretinogram, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

A Phase II Study Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma (PRORADGLIO Study)

A Phase II Study Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma (PRORADGLIO Study) is a PHASE2 clinical asset sponsored by Medical College of Wisconsin in Glioblastoma. SEO and diligence focus: Radiation, Concurrent Chemotherapy (Temozolomide), Adjuvant Chemotherapy (Temozolomide), endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

The Efficacy of Intra-oral Neuromuscular Stimulation Training on Snoring in Individuals With Primary Snoring or Mild Sleep Apnoea - A Multi Centre Trial

The Efficacy of Intra-oral Neuromuscular Stimulation Training on Snoring in Individuals With Primary Snoring or Mild Sleep Apnoea - A Multi Centre Trial is a NA clinical asset sponsored by Signifier Medical Technologies in Snoring, Sleep Apnea, Obstructive. SEO and diligence focus: eXciteOSA, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

STABICAN : Measurement of Implant Stability by Analysis of the Resonance Frequency in Patients Treated for Cancer of the Upper Aero-digestive Tract

STABICAN : Measurement of Implant Stability by Analysis of the Resonance Frequency in Patients Treated for Cancer of the Upper Aero-digestive Tract is a registry-stage clinical asset sponsored by Centre Leon Berard in Cancer. SEO and diligence focus: Implant placement, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

Intervention to Reduce Sitting Time in Mild Cognitive Impairment

Intervention to Reduce Sitting Time in Mild Cognitive Impairment is a NA clinical asset sponsored by University of Kansas Medical Center in Mild Cognitive Impairment. SEO and diligence focus: Jawbone Up, Physical Activity Education, ActivPAL, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

Clinical Trial to Evaluate the Efficacy and Security of Deep Brain Stimulation in Alzheimer´s Disease

Clinical Trial to Evaluate the Efficacy and Security of Deep Brain Stimulation in Alzheimer´s Disease is a NA clinical asset sponsored by Hospital San Carlos, Madrid in Alzheimer Disease. SEO and diligence focus: Deep brain stimulation (fornix), Deep brain stimulation (Basal nucleus of Meynert), endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

Feasibility of Prehospital Trans Esophageal Echocardiography in Cardiac Arrest

Feasibility of Prehospital Trans Esophageal Echocardiography in Cardiac Arrest is a NA clinical asset sponsored by Medical University of Vienna in Echocardiography, Transesophageal, Out-of-Hospital Cardiac Arrest. SEO and diligence focus: Transesophageal Echocardiography, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy: a Randomized, Non-comparative, Placebo-controlled, Single-blinded, Phase II Clinical Trial in Cancer Patients

Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy: a Randomized, Non-comparative, Placebo-controlled, Single-blinded, Phase II Clinical Trial in Cancer Patients is a NA clinical asset sponsored by Institut du Cancer de Montpellier - Val d'Aurelle in Cancer Survivors, Peripheral Neuropathic Pain. SEO and diligence focus: Photobiomodulation sessions, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

Effects of Neuromuscular Electrical Stimulation Combined With Resistance Exercises on Muscle Strength in Adult Hematological Cancer Patients: A Randomized Controlled Study

Effects of Neuromuscular Electrical Stimulation Combined With Resistance Exercises on Muscle Strength in Adult Hematological Cancer Patients: A Randomized Controlled Study is a NA clinical asset sponsored by Acibadem University in Hematologic Malignancy, Muscle Weakness. SEO and diligence focus: Neuromuscular Electrical Stimulation, Structured Exercise, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

A Multi-Center Prospective Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System

A Multi-Center Prospective Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System is a registry-stage clinical asset sponsored by Zimmer Biomet in Trauma, Tumor, Pseudarthrosis, Scoliosis, Degenerative Disc Disease. SEO and diligence focus: VueLock™ Anterior Cervical Plate, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

Safety and Feasibility of the ENDOPLY System in Humans: a Pilot Study

Safety and Feasibility of the ENDOPLY System in Humans: a Pilot Study is a NA clinical asset sponsored by ENDOPLY in Obesity. SEO and diligence focus: ENDOPLY System, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

Evaluation of a Mechanical Insufflation-exsufflation Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders: a Prospective, Randomized, Controlled, Multicenter Study

Evaluation of a Mechanical Insufflation-exsufflation Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders: a Prospective, Randomized, Controlled, Multicenter Study is a PHASE3 clinical asset sponsored by Assistance Publique - Hôpitaux de Paris in Duchenne Muscular Dystrophy, Amyotrophic Lateral Sclerosis, Neuromuscular Diseases. SEO and diligence focus: mechanical insufflation - exsufflation, Standard respiratory physiotherapy, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: medical device

MultI-eLectrode EndovaScular denervaTiOn in patieNts With Type 2 Diabetes mEllitus (MILESTONE) Study

The MILESTONE study, sponsored by Zhongda Hospital, aims to evaluate the efficacy of multi-electrode catheter-based endovascular denervation in improving glucose metabolism and insulin sensitivity in patients with Type 2 Diabetes Mellitus (T2DM). Given the increasing prevalence of T2DM globally, successful outcomes from this trial could position the intervention as a novel therapeutic option in a market characterized by a high demand for effective diabetes management solutions. The competitive landscape includes traditional pharmacological treatments and emerging technologies targeting metabolic pathways. Diligence should focus on the trial's recruitment progress, safety profile, and potential regulatory pathways, especially considering the device nature of the intervention.

Matched by modality_normalized: medical device

A Multicenter, International Randomized, 2x2 Factorial Design Study to Evaluate the Effects of Lantus (Insulin Glargine) Versus Standard Care, and of Omega-3 Fatty Acids Versus Placebo, in Reducing Cardiovascular Morbidity and Mortality in High Risk People With Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (IGT) or Early Type 2 Diabetes Mellitus: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)

The ORIGIN trial, sponsored by Sanofi, addresses significant unmet needs in the management of cardiovascular risks associated with impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and early type 2 diabetes mellitus. With an enrollment of over 12,500 participants across 40 countries, the trial's findings could reinforce the therapeutic positioning of insulin glargine and omega-3 fatty acids in a competitive diabetes and cardiovascular market. The results may support expanded indications for these agents, potentially enhancing market share against competitors like Novo Nordisk and Eli Lilly, which also target similar patient populations. The trial's completion and subsequent data readouts will be critical for informing market access strategies and reimbursement discussions.

Phase II Magnetic Alteration of Pectus Excavatum

The Magnetic Mini-Mover Procedure (3MP) represents a novel approach to treating pectus excavatum, a prevalent congenital chest wall deformity. The market for pectus excavatum treatments is primarily composed of surgical interventions, which can be invasive and carry significant risks. This non-invasive alternative could appeal to parents and patients seeking less traumatic options. Given the limited competition in non-surgical treatments for this condition, successful outcomes could position UCSF as a leader in pediatric chest wall deformity corrections. However, the commercial viability will depend on the robustness of clinical data, regulatory pathways, and potential reimbursement strategies. Diligence should focus on the long-term efficacy and safety data, as well as the potential for broader applications of magnetic therapies in other deformities.

Matched by modality_normalized: medical device

Mitigating Cutaneous Toxicity in Patients Undergoing TomoTherapy; A Randomized Controlled Trial of Skin-Protective Strategies

The study, sponsored by King Faisal Specialist Hospital & Research Center, aims to evaluate two skin-protective strategies for head and neck cancer patients undergoing TomoTherapy. Given the high incidence of radiation dermatitis (up to 84%) in this patient population, successful outcomes could position the selected intervention as a standard of care, potentially capturing a significant share of the supportive care market in oncology. The products being tested are affordable and widely available, which may facilitate adoption in clinical practice. However, the lack of established standards for managing radiation dermatitis presents both a challenge and an opportunity for differentiation in a competitive landscape dominated by traditional supportive care approaches.

Matched by modality_normalized: medical device

Analysis of Volatile Organic Compounds in Patients With Type 1 Diabetes in Induced Hypoglycaemia With a Breath Analyser

The study, sponsored by the University of Bern, aims to explore the relationship between VOCs and blood glucose levels in Type 1 Diabetes patients during induced hypoglycaemic episodes. This research could lead to innovative non-invasive monitoring technologies for diabetes management, potentially positioning the BreathSpec® device as a novel tool in the diabetes care market. Given the increasing prevalence of diabetes globally, advancements in monitoring technologies could capture significant market interest. However, the competitive landscape includes established glucose monitoring devices and continuous glucose monitoring (CGM) systems, necessitating a clear differentiation strategy for any resultant product. The study's completion in July 2024 may provide critical data for future commercialization efforts.

Matched by modality_normalized: medical device

Evaluation of the Impact of the FreeStyle Libre 2 Flash Glucose Monitoring System, Compared to the Current Standard of Care (SOC), on Weight Reduction in Subjects With Type 2 Diabetes.

The clinical trial aimed to evaluate the efficacy of the FreeStyle Libre 2 system in promoting weight reduction among individuals with Type 2 Diabetes compared to the current standard of care. The trial was terminated due to slow enrollment and the study being deemed no longer required. This outcome suggests potential challenges in market adoption or interest in the comparative efficacy of glucose monitoring systems for weight management. Abbott Diabetes Care may need to reassess its strategy regarding the FreeStyle Libre 2, particularly in the context of competitive offerings in diabetes management and weight loss solutions. The termination of the trial may also impact investor confidence and future funding opportunities for related research.

Matched by modality_normalized: medical device

Transcutaneous Electrical Acustimulation in Automatic Synchronization With Breathing for Treating Functional Dyspepsia: A Phase I Feasibility Trial

The AutoSTEA device, developed by MetroHealth Medical Center, aims to address functional dyspepsia, a condition affecting a significant portion of the adult population. The feasibility trial will assess both the efficacy and safety of the device, which could position it as a novel non-pharmacological treatment option in a market currently dominated by pharmacotherapy. Given the increasing prevalence of functional gastrointestinal disorders and the growing demand for at-home treatment solutions, successful outcomes could lead to a competitive advantage in the gastrointestinal device market. However, the trial's limited enrollment of 20 participants may pose challenges in establishing robust market claims. The focus on usability and safety is critical for patient acceptance and adherence, which are essential for commercial success.

Matched by modality_normalized: medical device

Myoelectric Devices for Restoration of Independent Arm Function in Children and Adults With Neurological Disease and Injury

The NuroSleeve study, sponsored by Thomas Jefferson University, aims to evaluate the efficacy of a novel powered arm brace combined with muscle stimulation for individuals with arm weakness or paralysis due to neurological conditions. The potential market for such devices is significant, given the prevalence of neurological disorders and the growing demand for assistive technologies that enhance independence in daily activities. If successful, this study could lead to the commercialization of the NuroSleeve, positioning it favorably against existing rehabilitation technologies. Competitive analysis should consider other myoelectric devices and rehabilitation solutions, as well as the regulatory landscape for medical devices in the U.S. and globally. Diligence implications include assessing the scalability of production, reimbursement pathways, and potential partnerships with rehabilitation centers and healthcare providers.

Feasibility of Telesurveillance and Home Cough Assistance for Amyotrophic Lateral Patients (ALS)

The trial conducted by Fondazione Salvatore Maugeri aims to evaluate the feasibility of a structured telesurveillance program combined with home cough assistance for ALS patients. Given the increasing prevalence of ALS and the need for innovative home care solutions, this program could represent a significant advancement in patient management, potentially reducing hospitalizations and improving quality of life. The market for ALS therapies and supportive care is growing, with increasing interest from both pharmaceutical companies and healthcare providers. The successful implementation of this program may enhance the competitive positioning of the sponsor in the ALS care landscape, particularly in telemedicine and home healthcare sectors. Diligence implications include assessing the scalability of the program and its cost-effectiveness compared to traditional care models.

Matched by modality_normalized: medical device

Diaphragmatic Pacer Placement: Anesthetic Management (DP)

The Diaphragmatic Pacer (DP) represents a significant advancement in the management of patients with chronic respiratory failure due to SCI and ALS. By potentially reducing reliance on mechanical ventilation, the DP could lead to improved patient quality of life and decreased healthcare costs associated with prolonged mechanical ventilation. The market for respiratory support devices is growing, driven by an increasing prevalence of neuromuscular disorders. Competitive analysis indicates that while there are existing mechanical ventilation solutions, the unique application of diaphragmatic pacing positions the DP as a differentiated offering. Diligence should focus on the long-term efficacy and safety data, as well as reimbursement pathways for the device, which could influence market adoption.

Matched by modality_normalized: medical device

Mechanistic Studies in Human Subcutaneous Adipose Tissue

The AMIGROS study, sponsored by Vastra Gotaland Region, aims to elucidate the role of galectin-1 in obesity and type 2 diabetes by comparing obese insulin-sensitive (Ob-IS) and insulin-resistant (Ob-IR) subjects with lean controls. Given the increasing prevalence of obesity and type 2 diabetes globally, understanding the mechanistic pathways involving galectin-1 could lead to novel therapeutic targets. The findings may have significant implications for drug development in metabolic disorders, particularly in identifying biomarkers for early intervention and personalized treatment strategies. The study's observational nature may limit immediate commercial applications but could pave the way for future clinical trials targeting galectin-1 modulation. The competitive landscape includes existing diabetes and obesity therapies, necessitating a robust differentiation strategy based on the mechanistic insights gained from this research.

Matched by modality_normalized: medical device

International, Prospective, Longterm Study Comparing the Clinical Outcome and In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis

The study sponsored by Aesculap AG aims to evaluate the in-vivo wear behavior of the Columbus® total knee prosthesis with a focus on comparing the standard Cobalt Chromium (CoCr) version against the Advanced Surface (AS) coated variant. The termination of the trial due to slow recruitment raises concerns about market interest and the potential for competitive positioning against other knee prosthesis manufacturers. The findings could influence market adoption of the AS technology, impacting Aesculap's market share in the orthopedic implant sector. Additionally, the collaboration with Raylytic GmbH may enhance data analytics capabilities, providing a competitive edge in future product development and marketing strategies.

Matched by modality_normalized: medical device

The Effect of Low-dye Kinesio Taping in Addition to Extracorporeal Shock Wave Therapy in Patients With Plantar Fasciitis

The clinical trial conducted by Hitit University investigates the combined efficacy of low-dye Kinesio taping and extracorporeal shock wave therapy (ESWT) for treating plantar fasciitis, a prevalent condition that significantly impacts quality of life and workforce productivity. With a growing market for orthopedic treatments and rehabilitation therapies, successful outcomes could position the sponsoring institution as a leader in non-invasive treatment modalities. The trial's completion and positive results may enhance the commercial viability of Kinesio taping as a standard adjunct therapy in managing plantar fasciitis, potentially leading to partnerships with medical device manufacturers or rehabilitation centers. Competitive implications include the need to monitor similar studies and therapies in the market, particularly those focusing on conservative treatment options for musculoskeletal pain.

A Pilot Study on App-based Treatment Combining Physical Exercise, Graded Activity, and Pain Journaling for Patients with Spinal Complaints

The pilot study sponsored by Zuyderland Medisch Centrum aims to evaluate an innovative app-based treatment for patients with spinal complaints, addressing a significant and growing healthcare burden. The increasing prevalence of spinal issues, particularly in aging populations, presents a substantial market opportunity for digital health solutions. The app's potential to enhance patient engagement, provide personalized treatment, and reduce healthcare costs positions it favorably against traditional therapies. However, the competitive landscape includes established physical therapy practices and emerging digital health solutions, necessitating thorough market diligence to assess adoption barriers and reimbursement pathways.

Matched by modality_normalized: medical device

Use of 7T Multimodal Imaging to Detect Brain Changes Associated With Light Therapy in Persons With Mild Cognitive Impairment and Mild Alzheimer's Disease

The study sponsored by the Icahn School of Medicine at Mount Sinai aims to explore the effects of light therapy on sleep, memory, and brain function in patients with Mild Cognitive Impairment (MCI) and Mild Alzheimer's Disease (AD). Given the prevalence of sleep disturbances in these populations, which can affect overall health and cognitive function, successful outcomes could lead to the development of innovative light-delivery methods that address these issues. The potential market for cognitive enhancement therapies in aging populations is significant, particularly as the global prevalence of Alzheimer's disease continues to rise. The findings may position the sponsor favorably within the growing field of non-pharmacological interventions for cognitive disorders, although competition from existing and emerging therapies will need to be monitored closely.

Matched by modality_normalized: medical device

A Pilot Study to Evaluate the Use of the MN4000 for Treatment of Cystic Fibrosis (CF) and Motor Neuron Disease (MND) Patients in the Home Setting

The MN4000, marketed as The MetaNeb® System, is a Class II medical device cleared for home use in patients with Cystic Fibrosis (CF) and Motor Neuron Disease (MND). The pilot study demonstrated feasibility in a home setting, with a focus on patient satisfaction and adherence. Given the increasing prevalence of CF and MND, the device addresses a significant market need for effective home-based respiratory therapies. Competitive positioning may be strengthened by positive patient feedback and adherence metrics, which could support future regulatory submissions for expanded indications or larger-scale studies. Diligence should focus on reimbursement pathways and potential partnerships with healthcare providers for broader adoption.

Matched by modality_normalized: medical device

Single Neuron Population Dynamics in Human Speech Motor Cortex for a Speech Prosthesis

The BrainGate2 Neural Interface System aims to provide a novel solution for individuals with severe speech impairments, particularly those suffering from conditions like ALS. The potential market includes a significant population of patients with anarthria and dysarthria, representing a niche yet impactful segment within the assistive technology landscape. The competitive landscape includes other neuroprosthetic devices, but the unique focus on speech restoration may offer a distinct advantage. Successful outcomes could lead to partnerships with rehabilitation centers and technology firms, enhancing market penetration. Diligence implications include assessing regulatory pathways and reimbursement strategies, given the unapproved status of the device.

Matched by modality_normalized: medical device

A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma

The trial, led by Giselle Sholler, aims to assess the feasibility of using the OncInsights technology for personalized treatment planning in patients with refractory or recurrent neuroblastoma. Given the limited treatment options for this patient population, successful outcomes could position OncInsights as a valuable tool in precision oncology, potentially leading to partnerships with pharmaceutical companies focused on neuroblastoma therapies. The market for pediatric oncology is growing, and advancements in molecular-guided therapies may enhance competitive positioning against traditional treatment modalities. Diligence should focus on regulatory pathways, as the technology is not yet FDA-approved, and on the potential for scalability in clinical practice.

Matched by modality_normalized: medical device

Phase II Clinical Study on the Safety and Efficacy of Autotransfusion Agents Targeting CD19 Chimeric Antigen Receptor T Lymphocytes (BIC-19GG, BIC-2019,BIC-2219)in the Treatment of CD19-positive Children With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma

The Phase II study evaluates the safety and efficacy of three autotransfusion agents (BIC-19GG, BIC-2019, BIC-2219) targeting CD19 in pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma. Given the high unmet medical need in this patient population, successful outcomes could position these agents favorably in the competitive landscape of CAR T-cell therapies, which have shown promise but also face challenges such as high costs and adverse effects. The market for CAR T-cell therapies is expanding, with significant investment and interest from major biopharmaceutical companies, indicating potential for lucrative partnerships or acquisitions if the trial demonstrates positive results.

Matched by modality_normalized: medical device

The Impact of a Locally Tailored Evidence-based Chinese Smartphone Application in Management of Type 1 Diabetes Mellitus Aged 6-18 Years in Hong Kong - a Randomized Controlled Trial

This clinical trial, sponsored by the Chinese University of Hong Kong, addresses a significant gap in diabetes management for pediatric patients in Hong Kong, where no Chinese-language smartphone applications currently exist. The trial aims to evaluate the effectiveness of a tailored application that incorporates local clinical practices and cultural dietary considerations. Given the high smartphone penetration among the youth in Hong Kong, the potential market for such an application is substantial. If successful, this initiative could lead to a competitive advantage in the digital health space, particularly for companies focusing on diabetes management solutions. The trial's outcomes could also attract interest from investors and stakeholders in the digital therapeutics sector, emphasizing the importance of culturally relevant healthcare solutions.

An In-home Study of Brain Computer Interfaces

The University of Michigan's study on brain-computer interfaces (BCIs) aims to enhance the independence of individuals with severe paralysis, particularly those with Amyotrophic Lateral Sclerosis (ALS). The market for assistive technologies is growing, driven by an increasing aging population and rising prevalence of neurological disorders. The unique nature of this BCI technology, which allows users to control wheelchairs and communicate, positions it competitively against existing assistive devices. However, the limited enrollment (only one participant) raises concerns regarding scalability and market viability. Further exploration of user experience and technology refinement will be critical for commercial success.

Matched by modality_normalized: medical device

Second Phase of "Carotid RX ACCULINK/RX ACCUNET Post-Approval Trial to Uncover Unanticipated or Rare Events"

The CAPTURE 2 trial, sponsored by Abbott Medical Devices, serves as a critical post-market surveillance mechanism for the RX ACCULINK and RX ACCUNET systems. With an enrollment of 6,426 patients across approximately 400 clinical sites in the U.S., the registry aims to document clinical outcomes and assess the safety of these devices under commercial use conditions. The trial's completion in May 2010 positions Abbott favorably in the carotid artery disease market, which is characterized by increasing demand for minimally invasive procedures. The data collected may enhance Abbott's competitive edge by demonstrating the efficacy and safety of its devices, potentially influencing physician adoption and reimbursement strategies. Furthermore, the evaluation of physician training programs could lead to improved outcomes and reduced liability for Abbott, reinforcing its market position.

Matched by modality_normalized: medical device

6-Hz Primed Low and High-Frequency Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Children With Cerebral Palsy: TMS-EEG Study

The TMS-EEG study sponsored by Cook Children's Health Care System aims to investigate the therapeutic potential of rTMS in improving motor function in children with Cerebral Palsy (CP). Given the high prevalence of CP and the significant long-term healthcare costs associated with its management, successful outcomes could position this intervention as a valuable addition to pediatric rehabilitation therapies. The study's focus on enhancing neural plasticity may attract interest from healthcare providers and payers seeking innovative solutions to reduce rehabilitation times and costs. Additionally, the use of advanced neuroimaging techniques like TMS-EEG may enhance the study's credibility and appeal to potential investors and collaborators in the neurotherapeutics space.

Matched by modality_normalized: medical device

Understanding Circadian Responses to Light in Persons With Mild Cognitive Impairment and Alzheimer's Disease

The study conducted by the Icahn School of Medicine at Mount Sinai aims to explore the effects of different light conditions on melatonin levels and memory in individuals with mild cognitive impairment and healthy controls. Given the increasing prevalence of Alzheimer's disease and related cognitive disorders, this research could lead to novel therapeutic strategies that leverage light exposure to improve cognitive function. The findings may have significant implications for the development of light-based interventions or devices targeting circadian rhythms, potentially creating a new market segment within cognitive health and wellness. Competitively, this study positions the sponsor at the forefront of innovative approaches to managing cognitive decline, although further research and validation will be necessary to establish clinical efficacy and market viability.

Matched by modality_normalized: medical device

Imaging Myelin Injury in Amyotrophic Lateral Sclerosis (ALS)

The study, sponsored by Johns Hopkins University, aimed to explore the potential of 7 Tesla MRI as a diagnostic tool for assessing myelin injury in ALS patients. Although the trial was withdrawn, the insights gained could inform future research and development in ALS diagnostics. The ALS market is characterized by a growing demand for innovative diagnostic techniques, particularly those that can predict disease progression. Companies focusing on neurodegenerative diseases may find strategic opportunities in developing imaging technologies or biomarkers that correlate with clinical outcomes, especially as the ALS patient population continues to seek effective management options.

Matched by modality_normalized: medical device

A Pilot Study Assessing a New Eye-writing Device Allowing Cursive Writing With Smooth Pursuit Eye Movements in Subjects With ALS

The Eye On Line (EOL) device represents a novel approach to assist ALS patients in communication, addressing a significant unmet need in this patient population. The market for assistive communication devices is growing, driven by the increasing prevalence of neurodegenerative diseases. The EOL device's unique mechanism of utilizing smooth pursuit eye movements for writing could differentiate it from existing solutions, potentially capturing a niche market. Competitive analysis indicates a limited number of similar devices, suggesting a favorable position for EOL if proven effective. Diligence should focus on regulatory pathways, reimbursement strategies, and partnerships with ALS advocacy groups to enhance market penetration.

Matched by modality_normalized: medical device

Continuous Glucose Monitoring Among Individuals With Gestational Diabetes Treated With Metformin Versus Insulin: Protocol for a Nested Prospective Cohort in the DECIDE RCT (DECIDE CGM)

The DECIDE CGM study, sponsored by Ohio State University, aimed to evaluate the effectiveness of Continuous Glucose Monitoring (CGM) in managing gestational diabetes treated with Metformin compared to Insulin. The study's withdrawal indicates a strategic focus on the parent DECIDE trial, which may impact the development of CGM technologies in this therapeutic area. The market for diabetes management, particularly in pregnancy, remains competitive with significant players like Dexcom, Inc. and Abbott Laboratories. The findings from the parent trial could influence treatment protocols and market positioning for both Metformin and Insulin in GDM management, as well as CGM device adoption in clinical practice.

Matched by modality_normalized: medical device

Levonorgestrel-releasing Intrauterine Device Effects on Hemostatic and Arterial Function of Obese Women

The clinical trial, sponsored by the University of Sao Paulo, investigates the effects of the levonorgestrel-releasing intrauterine device (IUS-LNG) on arterial function and hemostatic parameters in obese women, particularly those with polycystic ovary syndrome (PCOS). Given the rising prevalence of obesity and associated cardiovascular risks, this study addresses a significant unmet need in contraceptive options for this demographic. The findings could enhance the market positioning of IUS-LNG as a safer contraceptive alternative for obese women, potentially leading to increased adoption in clinical practice. Competitive implications include the need for differentiation from other contraceptive methods, particularly non-hormonal options like the Copper IUD, which serves as the comparator in this trial. Diligence considerations should focus on the long-term safety and efficacy data, particularly concerning cardiovascular health outcomes.

Auditory Rehabilitation With Hearing Aids and Cognition in Alzheimer Patients

The trial, sponsored by University Hospital, Tours, investigates the impact of auditory rehabilitation on cognitive decline in Alzheimer's patients, a growing demographic with significant unmet needs. The market for hearing aids is expanding, particularly among the elderly population, which is increasingly affected by both hearing loss and cognitive disorders. If the trial demonstrates efficacy, it could position hearing aids as a critical component of Alzheimer's care, potentially leading to increased adoption and sales in this segment. Competitive analysis should focus on existing cognitive therapies and hearing aid manufacturers, assessing their market strategies and product offerings. Due diligence should include evaluating regulatory pathways and reimbursement scenarios in France and other European markets.

Matched by modality_normalized: medical device

Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients With Type 2 Diabetes Mellitus

The DJBL represents a novel, reversible intervention for managing obesity and T2DM, addressing a significant unmet need in the market for patients who have not succeeded with traditional weight loss methods. Given the rising prevalence of obesity and diabetes globally, this device could capture a substantial share of the weight loss and diabetes management market. The competitive landscape includes traditional bariatric surgeries and pharmacological interventions, but DJBL's non-invasive nature may offer a distinct advantage. Diligence considerations should focus on long-term efficacy, safety data, and potential regulatory pathways for commercialization.

Matched by modality_normalized: medical device

Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients (BWL001)

The BWL001 trial, sponsored by the Jonsson Comprehensive Cancer Center, targets a niche yet critical market segment of adolescents and young adults who are obese following hematopoietic stem cell transplantation (HSCT). This population is often overlooked in weight management interventions, presenting a unique opportunity for the development of tailored behavioral health solutions. The integration of mobile health technology and coaching may enhance patient engagement and adherence, potentially leading to improved health outcomes. Given the rising prevalence of obesity in post-transplant patients, successful outcomes could position the intervention as a standard care approach, influencing market dynamics and attracting interest from healthcare providers and payers. Competitive landscape analysis should focus on existing obesity management solutions and mobile health applications, assessing their efficacy and market penetration.

Hypofractionated Radiotherapy for Prostate Cancer (62 Gy in 20 Fractions of 3.1 Gy) With Hyaluronic Acid Injection

The Phase II trial sponsored by Hospices Civils de Lyon investigates the efficacy of hyaluronic acid (HA) as a spacer to mitigate late rectal toxicities in patients undergoing hypofractionated radiotherapy for prostate cancer. With a focus on low- to intermediate-risk patients, this study could potentially enhance treatment tolerability and patient outcomes, thereby positioning HA as a valuable adjunct in prostate cancer radiotherapy. The reduction in treatment duration from 40 to 20 fractions may also appeal to healthcare providers seeking efficiency in treatment protocols. If successful, this could lead to broader adoption of HA in clinical practice, impacting market dynamics in the oncology space, particularly in radiotherapy adjuncts. Competitive analysis should consider existing spacer technologies and their market penetration, as well as the regulatory landscape for medical devices in oncology.

Matched by modality_normalized: medical device

Miniaturized Smart Sensor Device for the Detection of Hypo- and Hyperglycemic Events in Persons Diagnosed With Diabetes

The study, sponsored by Indiana University, aims to develop a miniaturized smart sensor device capable of noninvasively detecting hypo- and hyperglycemic events in diabetic patients through the analysis of VOCs in exhaled breath. This innovative approach could potentially disrupt the diabetes management market by providing a non-invasive alternative to traditional blood glucose monitoring methods. The target demographic includes children and young adults aged 7-25 with Type 1 and Type 2 diabetes, a segment that represents a significant portion of the diabetes population. If successful, this technology could enhance patient compliance and improve glycemic control, thereby addressing a critical need in diabetes care. The competitive landscape includes established continuous glucose monitoring (CGM) systems, but the non-invasive nature of this device may offer a unique selling proposition. Diligence should focus on regulatory pathways, potential partnerships for commercialization, and the scalability of manufacturing the sensor device.

GLYcemic Control Evaluation by Continuous Glucose Monitor Compared With a1C in Left Ventricular Assist Device-supported Patients (GLYCEM1C-LVAD)

The GLYCEM1C-LVAD study, sponsored by Mayo Clinic, aims to validate the use of hemoglobin A1c as a measure of glycemic control in patients with LVADs, a population that may experience unique challenges in diabetes management. The study leverages the Freestyle Libre 3 Continuous Glucose Monitor (CGM) to provide real-time glucose data, potentially leading to improved patient outcomes through better glycemic control. The findings could enhance the market positioning of CGM devices in specialized patient populations, indicating a growing need for tailored diabetes management solutions. The study's outcomes may influence future guidelines and reimbursement policies, thereby impacting market dynamics and competitive positioning among diabetes management technologies.

Matched by modality_normalized: medical device

Deep Brain Therapy With Low-intensity Ultrasound for Treatment of Cognitive Impairment

The trial, sponsored by the University of Utah, aims to evaluate a novel non-invasive therapeutic approach for Alzheimer's disease, a condition with significant unmet medical need and a growing market. The use of low-intensity ultrasound for cognitive impairment may position the Diadem prototype as a competitive alternative to existing pharmacological treatments, particularly if it demonstrates efficacy in improving cognitive outcomes. The Alzheimer's disease market is projected to reach $20 billion by 2025, highlighting the commercial potential of successful interventions. However, the termination of this trial due to IRB administrative closure raises concerns regarding regulatory compliance and operational viability, necessitating further diligence on the sponsor's capacity to navigate these challenges.

Matched by modality_normalized: medical device

Exploratory Study on the Effects of Lung Insufflation Capacity Training Using the LIC Trainer in Patients With Amyotrophic Lateral Sclerosis: A Single-Center Prospective Interventional Study

This exploratory study, sponsored by the National Center of Neurology and Psychiatry in Japan, investigates the potential of the LIC Trainer device to improve respiratory function and prolong survival in ALS patients. The market for ALS therapies is expanding, with a growing focus on supportive care and rehabilitation strategies. If successful, the findings could position the LIC Trainer as a pivotal tool in respiratory rehabilitation for ALS, potentially leading to commercial opportunities in both Japan and globally. The absence of a control group necessitates careful interpretation of results, and further studies may be required to substantiate efficacy claims. Competitive implications include the need to monitor other emerging therapies targeting respiratory function in ALS, as well as alternative rehabilitation devices.

Thin Wire Versus Thick Wire Snare for Cold Snare Polypectomy of Diminutive Polyps- A Randomised Controlled Trial

The trial compares the efficacy of thin versus thick wire snares in cold snare polypectomy, a common procedure for removing diminutive polyps. Given that approximately 90% of polyps are smaller than 10 mm, optimizing this technique could significantly impact clinical practice and patient outcomes. The results may influence market preferences for snare devices, potentially leading to increased adoption of thin wire snares if proven superior. This could also affect competitive dynamics among manufacturers of endoscopic devices, necessitating diligence on existing product portfolios and market positioning.

Matched by modality_normalized: medical device

Predicting Difficult Intubation in Obese Patients: The Role of Anthropometric Measurements and Ultrasonograpic Suprasternal Adipose Tissue Thickness

The study conducted by Ankara City Hospital Bilkent addresses a critical need in the anesthesiology field, particularly concerning the management of obese patients undergoing elective abdominal surgery. With obesity rates rising globally, the ability to predict difficult intubation could significantly reduce complications and improve surgical outcomes. The findings may lead to the development of new guidelines or tools for anesthesiologists, potentially creating a market for devices or software that utilize these predictive measurements. Competitors in the field may include companies focused on surgical and anesthetic devices, as well as those developing AI-driven predictive analytics for patient management. Diligence should focus on the integration of these findings into clinical practice and the potential for patenting any novel methodologies or devices that arise from this research.

Efficacy of Gamification in Enhancing User Engagement in Visual Mapping Assistive Technology

MapHabit, Inc. is exploring the efficacy of gamification in its assistive technology aimed at individuals with mild to moderate Alzheimer's disease and related dementias. The market for dementia care technologies is expanding, driven by an increasing aging population and a growing need for innovative solutions to improve patient engagement and caregiver support. The competitive landscape includes various digital health solutions targeting dementia care, but few incorporate gamification as a core feature. Successful outcomes from this trial could position MapHabit favorably in the market, potentially leading to partnerships or acquisition interest from larger healthcare companies. Diligence should focus on the scalability of the technology and the regulatory landscape, given that the MapHabit system is not classified as a regulated medical device.

Matched by modality_normalized: medical device

Real World Testing of a Brain-Computer Interface to Operate a Commercial Augmentative and Alternative Communication System

The University of Pittsburgh's clinical trial focuses on the innovative application of BCI technology to enhance communication for individuals with severe disabilities, such as ALS, TBI, and cerebral palsy. The market for AAC devices is expanding, driven by increasing awareness and demand for assistive technologies. This study's findings could position the University of Pittsburgh as a leader in the AAC-BCI space, potentially attracting partnerships or funding from healthcare providers and technology developers. Competitive implications include the need to monitor existing AAC solutions and emerging BCI technologies that may enter the market. Diligence considerations should include assessing the scalability of the technology and its integration into existing healthcare frameworks.

Matched by modality_normalized: medical device

The Induction of IL-6 by NF-kB in PBMC in OSA

The study, sponsored by National Taiwan University Hospital, investigates the role of IL-6 and NF-kB in patients with severe obstructive sleep apnea syndrome (OSAS). Given the increasing recognition of OSAS as a significant risk factor for cardiovascular diseases, the findings could have substantial implications for therapeutic interventions, particularly in the development of anti-inflammatory strategies. The potential market for CPAP devices and related therapies is significant, especially as awareness of OSAS and its comorbidities grows. Companies focusing on sleep medicine and inflammatory pathways may find strategic opportunities for collaboration or acquisition based on the outcomes of this study.

Matched by modality_normalized: medical device

A Study to Examine the Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer's Disease

This study, sponsored by Yale University, investigates the effects of timed therapeutic light on sleep and circadian rhythms in women with Alzheimer's Disease (AD). Given the increasing prevalence of AD, particularly among women, there is a growing market for interventions that address sleep disturbances associated with this condition. The results may position the therapeutic light intervention as a supportive care option, potentially leading to partnerships with device manufacturers or healthcare providers focused on AD management. Competitive implications include the need to assess existing therapies targeting sleep disorders in AD, as well as the potential for intellectual property development around the specific light therapy protocols used in this study.

Matched by modality_normalized: medical device

Conversational Engagement as a Means to Delay Alzheimer's Disease Onset

The study conducted by Oregon Health and Science University explored the potential of conversation-based cognitive stimulation to delay the onset of Alzheimer's Disease in non-demented elderly participants. Given the increasing prevalence of Alzheimer's and the aging population, this intervention could represent a cost-effective, scalable approach to cognitive health management. The results may position the sponsor favorably in the behavioral intervention market, which is gaining traction as an adjunct to pharmacological treatments. The competitive landscape includes other cognitive enhancement strategies, but this study's unique focus on social engagement could differentiate it. Diligence should focus on the scalability of the intervention and potential partnerships with healthcare providers and senior living communities.

Matched by modality_normalized: medical device

Is the Use of Drain for Thyroid Surgery Realistic?

The study conducted by Maltepe University evaluates the necessity of suction drains in thyroid surgery, a common practice aimed at preventing postoperative complications such as hematoma and seroma. With 400 patients enrolled, the findings could influence surgical protocols and potentially reduce hospital stays and healthcare costs if drains are deemed unnecessary. The results may have implications for surgical device manufacturers and healthcare providers, as a shift in practice could affect market demand for drainage devices. Additionally, the study's completion and publication could enhance the institution's reputation in surgical research, potentially attracting further funding and collaborations.

Matched by modality_normalized: medical device

Impact of Hypno-analgesia, Non-drugs Technique of Care, on Pain That May Inverve During a Lumbar Puncture for Diagnosis of Patient With Mild to Moderate Alzheimer's Dementia.

The clinical trial, sponsored by the University Hospital of Montpellier, aimed to evaluate the efficacy of hypno-analgesia combined with EMLA patch versus standard care in reducing pain during lumbar punctures in patients with mild to moderate Alzheimer's disease. The trial was withdrawn due to internal organizational issues and dysfunction of study materials, indicating potential challenges in operational execution. The market for Alzheimer's diagnostics and associated procedures remains significant, with a growing focus on patient-centered care and non-pharmacological interventions. Companies investing in innovative pain management solutions may find opportunities in this space, particularly as the demand for improved patient experiences in invasive procedures increases.

Matched by modality_normalized: medical device

P300 Brain Computer Interface Keyboard to Operate Assistive Technology

The P300 Brain Computer Interface Keyboard study, sponsored by the University of Michigan, aims to develop a BCI that enables individuals with paralysis to operate technology using brain signals. This innovative approach addresses a significant market need for assistive technologies, particularly for conditions such as Amyotrophic Lateral Sclerosis, spinal cord injuries, and other neuromuscular diseases. The successful development and commercialization of this technology could position the University of Michigan as a leader in the assistive technology market, which is projected to grow significantly due to increasing demand for adaptive devices. Competitive implications include potential partnerships with technology companies specializing in assistive devices and software, as well as the need to navigate existing patents in the BCI space to ensure freedom-to-operate.

Matched by modality_normalized: medical device

Effect of Bio-electromagnetic Energy Regulation Therapy on Erectile Dysfunction in Patients With Multiple Sclerosis

This clinical trial, sponsored by Imam Abdulrahman Bin Faisal University, explores the efficacy of BEMER therapy on erectile dysfunction (ED) in male patients with relapsing-remitting multiple sclerosis (RRMS). Given the significant prevalence of ED in MS patients and the limited treatment options available, a successful outcome could position BEMER therapy as a novel intervention in a niche market. The trial's findings may attract interest from pharmaceutical companies and medical device manufacturers looking to expand their portfolios in sexual health and neurology. However, the lack of FDA regulation for the device may limit its marketability in certain regions. Competitive analysis should consider existing ED treatments and emerging therapies targeting similar patient demographics.

Childhood Liver Disease Research Network (ChiLDReN): FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE) Study Protocol

The FORCE study, sponsored by Arbor Research Collaborative for Health, addresses a significant unmet need in pediatric hepatology by evaluating the non-invasive FibroScan™ technology for monitoring liver fibrosis in children with chronic cholestatic liver diseases. Given the limitations of liver biopsy, this study could pave the way for broader adoption of non-invasive techniques in clinical practice, potentially leading to increased market demand for FibroScan™ devices. The pediatric liver disease market is growing, driven by rising incidences of conditions like biliary atresia and Alagille syndrome. Companies involved in non-invasive liver assessment technologies may find strategic opportunities for partnerships or acquisitions based on the outcomes of this study.

Matched by modality_normalized: medical device

QT Interval Abnormalities in Sulfonylurea Treated Type 2 Diabetes: Relationship to Treatment Induced Hypoglycaemia and Glycaemic Variability Determined by Simultaneous Ambulatory Monitoring

This study, sponsored by the Royal Prince Alfred Hospital in Sydney, Australia, investigates the relationship between hypoglycaemia and QT interval abnormalities in patients with Type 2 Diabetes Mellitus (T2DM) treated with sulfonylureas. Given the increasing focus on cardiovascular safety in diabetes treatments, particularly in light of findings from major trials (ACCORD, ADVANCE, VADT), this research addresses a critical area of concern for both clinicians and pharmaceutical companies. The results may influence treatment guidelines and the development of new therapies, potentially impacting market dynamics for diabetes medications, especially sulfonylureas. Companies involved in diabetes care should monitor these findings closely for implications on product safety profiles and market positioning.

Matched by modality_normalized: medical device

A Single Arm Study of Resting State Functional Magnetic Resonance Imaging (Rs-fMRI)-Guided Theta Burst Stimulation (TBS) in Early-Stage Alzheimer's Disease (AD)

This pilot study sponsored by HealthPartners Institute explores a novel non-invasive treatment for early-stage Alzheimer's disease (AD) using rs-fMRI-guided iTBS. Given the limited efficacy of existing FDA-approved AD medications, this approach may represent a significant advancement in AD management, potentially addressing a substantial unmet medical need. The Alzheimer's market is projected to grow significantly, driven by the increasing prevalence of the disease, which currently affects 6.2 million individuals in the U.S. alone. The study's completion and subsequent results could position HealthPartners Institute favorably in the competitive landscape of AD therapies, particularly if efficacy is demonstrated. However, the absence of expanded access may limit immediate commercial opportunities.

Matched by modality_normalized: medical device

Evaluation of Dual-hormone Artificial Pancreas With Closed-loop Glucose Control Versus Single-hormone With Carbohydrate Recommendations Under Unannounced Exercise and Meal Challenge in Adults With Type 1 Diabetes.

The trial, sponsored by Universitat Politècnica de València, evaluates a dual-hormone artificial pancreas system against a single-hormone configuration in adults with Type 1 Diabetes (T1D). The dual-hormone approach aims to reduce hypoglycemic events and improve time in target glucose range, addressing a significant unmet need in diabetes management. The market for diabetes management technologies is expanding, with increasing adoption of automated insulin delivery systems. Successful outcomes could position the dual-hormone system as a competitive alternative to existing single-hormone systems, potentially enhancing patient adherence and outcomes. Companies in the diabetes technology space should monitor this trial closely for implications on product development and market positioning.

Matched by modality_normalized: medical device

Stroke Rehabilitation Using BCI Technology

The study sponsored by the University of Wisconsin, Madison, investigates the efficacy of active versus passive functional electrical stimulation (FES) in stroke rehabilitation. The potential for BCI technology to enhance recovery outcomes presents significant commercial opportunities in the rehabilitation market, particularly for stroke patients with upper-limb hemiparesis. The findings could position the sponsor as a leader in innovative rehabilitation solutions, attracting interest from healthcare providers and investors. Competitive implications include the need to monitor advancements in similar technologies and therapies targeting stroke recovery, as well as potential partnerships or licensing opportunities with medical device manufacturers.

Matched by modality_normalized: medical device

BioXmark Liquid Fiducials to Enable Radiotherapy Tumor Boosting in Rectal Cancer, a Feasibility Trial

The BioXmark liquid fiducial markers are being evaluated for their feasibility and accuracy in enhancing image-guided radiotherapy for rectal cancer. The trial, sponsored by Maastricht Radiation Oncology, involves a small cohort of 20 patients and aims to establish the markers' positional stability and visibility during treatment. If successful, this technology could improve treatment precision in rectal cancer, potentially leading to broader adoption in clinical practice. The market for rectal cancer therapies is significant, with increasing demand for innovative solutions that enhance treatment outcomes. Competitive implications include the potential for BioXmark to differentiate itself in a crowded oncology market, particularly if it demonstrates superior efficacy in guiding radiotherapy. Diligence considerations should focus on the regulatory pathway for the device and any existing competition in the fiducial marker space.

Matched by modality_normalized: medical device

Prospective Assessment of Risk Factors for Appropriate ICD Intervention in Patients With Ischemic Cardiomyopathy

The PARCADIA study, sponsored by Biotronik SE & Co. KG, aims to identify predictors for appropriate ICD interventions in patients with ischemic cardiomyopathy. Given the increasing prevalence of heart failure and the associated healthcare costs, this study addresses a significant unmet need in risk stratification for ICD therapy. The findings could enhance patient selection for ICD implantation, potentially improving clinical outcomes and reducing unnecessary healthcare expenditures. The competitive landscape includes other companies developing advanced imaging techniques and risk stratification tools, necessitating diligence in assessing market positioning and potential partnerships.

Matched by modality_normalized: medical device

Assessment of the Efficacy and Safety of a New Medical Device in the Local Treatment of Diabetic Foot Ulcers: a Prospective, Randomized, Controlled, Double-blind, European Multicentre Clinical Trial

Laboratoires URGO is conducting a multicenter clinical trial to evaluate the efficacy and safety of a new medical device containing LU3103209 for the treatment of diabetic foot ulcers (DFUs). The trial's design, which includes a randomized, double-blind approach, positions it well for potential market entry if successful. The diabetic foot ulcer treatment market is significant, driven by the increasing prevalence of diabetes and associated complications. If LU3103209 demonstrates superior efficacy compared to the control, it could capture a notable share of this market, especially given the limited effective treatments currently available. Competitive analysis indicates that successful outcomes could enhance URGO's position against existing therapies and devices in the wound care sector. Diligence will be required to assess regulatory pathways and reimbursement strategies post-trial completion.

Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging

The study conducted by Loma Linda University aims to establish normative values for cerebral blood flow (CBF) across various brain regions using a novel MRI technique. This non-invasive method has potential applications in diagnosing and managing brain disorders such as traumatic brain injury, multiple sclerosis, and Alzheimer's disease. The successful establishment of normative CBF values could enhance the reliability of pCASL MRI in clinical settings, positioning it as a competitive alternative to existing imaging modalities. The market for advanced neuroimaging techniques is growing, driven by increasing incidences of neurological disorders and the demand for non-invasive diagnostic tools. Companies developing or utilizing similar imaging technologies may face competitive pressures, and the findings from this study could influence their product development strategies.

Matched by modality_normalized: medical device

Testing the Gravitostat in Humans: the Impact of a Weighted Vest in Patients Post Bariatric Surgery on Fat-free Mass Retention and Weight Loss

The trial, sponsored by University College Dublin, aims to explore the impact of a weighted vest on fat-free mass retention and weight loss in patients post-bariatric surgery. Given the rising prevalence of obesity and the increasing number of bariatric surgeries performed globally, successful outcomes from this study could position the findings as a novel adjunctive therapy in weight management. The market for obesity treatments is substantial, with a growing demand for effective post-operative care solutions. However, the trial's suspension due to funding issues raises concerns regarding its viability and the potential for future commercialization. Competitors in the obesity management space may include pharmaceutical interventions and other non-invasive devices, necessitating a thorough competitive analysis.

Matched by modality_normalized: medical device

Development of Memesto Wearable Repetitive Message/Music Therapy Device That Senses and Reduces Agitation in Alzheimer's Disease and Alzheimer's Disease Related Dementia (AD/ADRD) Individuals

The Memesto device, developed by Edgewater Safety Systems, targets a significant unmet need in the management of agitation in AD/ADRD patients, a condition affecting approximately 70% of the 7.2 million individuals in the U.S. The device aims to reduce reliance on pharmacological interventions, thereby potentially lowering healthcare costs and improving patient quality of life. The market for dementia care solutions is growing, driven by an aging population and increasing prevalence of dementia-related disorders. Competitive analysis indicates a limited number of direct competitors in the wearable therapeutic device space for dementia, positioning Memesto favorably. The successful completion of this trial could enhance Edgewater's market position and attract potential partnerships or acquisitions from larger healthcare entities focused on innovative dementia care solutions.

Quantitative Electroencephalography to Longitudinally Assess the Functional Brain Signature of Treatment-resistant Depression and Recovery With Therapeutic Neuromodulation

This clinical trial, sponsored by Sunnybrook Health Sciences Centre, investigates the efficacy of rTMS combined with dry quantitative EEG (qEEG) technology to personalize treatment for patients with treatment-resistant depression. The market for depression treatments is substantial, with increasing demand for innovative therapies that address unmet needs. The use of qEEG may provide a competitive edge by enabling real-time monitoring of brain activity and treatment response, potentially leading to improved patient outcomes and reduced relapse rates. Given the rising prevalence of depression globally, successful outcomes could position the sponsor favorably within the neuromodulation market, which is projected to grow significantly. Diligence should focus on the scalability of the qEEG technology and the regulatory landscape surrounding neuromodulation devices.

Use of Continuous Glucose Monitoring Devices Among People Living With Type 1 Diabetes in Kenya: A Three-arm Pragmatic Randomized Study on the Effectiveness, Feasibility, Acceptability, and Cost.

The study, sponsored by the Foundation for Innovative New Diagnostics, aims to evaluate the effectiveness, feasibility, acceptability, and cost of continuous versus intermittent use of CGMs among individuals with Type 1 diabetes in Kenya. Given the increasing prevalence of diabetes in low- and middle-income countries (LMICs) and the potential for CGMs to improve patient outcomes, this study could inform clinical models for integrating CGMs into standard diabetes care. The findings may enhance market access for CGM manufacturers and influence pricing strategies, particularly in LMICs where cost is a significant barrier. The collaboration with local diabetes management centers and charitable trusts suggests a strong commitment to addressing healthcare disparities, which may enhance the sponsor's reputation and foster partnerships in future initiatives.

Matched by modality_normalized: medical device

Ultrasound-Guided Optimization of Inspiratory Pressure During Facemask Ventilation in Morbidly Obese Patients to Prevent Gastric Insufflation: A Randomized Clinical Trial

This clinical trial, sponsored by Benha University, aims to address a significant challenge in anesthetic management for morbidly obese patients (BMI ≥ 40 kg/m²) undergoing elective surgery. The focus on optimizing inspiratory pressure during facemask ventilation could lead to improved patient outcomes by reducing the risk of gastric insufflation, a common complication in this demographic. The use of ultrasound for real-time monitoring positions this trial at the intersection of anesthesiology and advanced imaging technology, potentially opening avenues for partnerships with medical device manufacturers and enhancing the competitive landscape in anesthesia management solutions. The trial's outcomes may also inform clinical guidelines, influencing market dynamics in anesthesia practices and training.

Matched by modality_normalized: medical device

Evaluation of the Effect of Respiratory Physiotherapy by Mechanical In-exsufflator on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis: A Pilot Study

This pilot study, sponsored by the University Hospital of Toulouse, aims to evaluate the efficacy of the Mechanical In-Exsufflator (MIE) in improving respiratory function in patients with Amyotrophic Lateral Sclerosis (ALS). Given the lack of curative treatments for ALS, this study could position MIE as a supportive therapeutic device in respiratory management, potentially enhancing patient quality of life. The market for ALS management is growing, with increasing focus on supportive therapies. The results of this study may influence future reimbursement policies and market access strategies for MIE devices in Europe and beyond. Competitive implications include the need to monitor other respiratory support devices and therapies targeting ALS and similar neurodegenerative conditions.

Matched by modality_normalized: medical device

A Post-market,monocentric,randomised,open-label,parallel Group,prospective Clinical Study Evaluating the Functional Outcome of the Kinematic Physica KR Total Knee Replacement System Vs the Standard Physica CR Total Knee Replacement System

The clinical trial, sponsored by Limacorporate S.p.a, aimed to evaluate the functional outcomes of two knee replacement systems: the Kinematic Physica KR and the Standard Physica CR. The trial was terminated due to enrollment issues, which may indicate challenges in market acceptance or competition. The knee replacement market is highly competitive, with numerous established players. The results of this study could influence the positioning of Limacorporate's products in a market that increasingly values patient-reported outcomes and functional recovery metrics. The trial's focus on a post-market evaluation suggests that the company is seeking to bolster its product's clinical profile to enhance market penetration and address potential concerns regarding performance compared to competitors.

Matched by modality_normalized: medical device

A Pilot Study to Assess the Feasibility of the Symphion® Bipolar Hysteroscopic Tissue Resection System in an Office Environment

Minerva Surgical, Inc. has completed a pilot study assessing the feasibility of the Symphion® Bipolar Hysteroscopic Tissue Resection System in an office environment. The study involved 10 female participants and aimed to evaluate the safety and feasibility of the device for removing intracavitary polyps and myomas. Given the increasing trend towards outpatient procedures in gynecology, this device could capture a significant share of the market focused on minimally invasive treatments. However, the competitive landscape includes established players in the hysteroscopic device market, necessitating a robust marketing strategy and potential partnerships to enhance market penetration. Diligence should focus on regulatory pathways and reimbursement strategies to ensure commercial viability.

Matched by modality_normalized: medical device

Minimally Invasive Surgical Therapy Consortium for Benign Prostatic Hyperplasia

The MIST trial, sponsored by the NIDDK, aimed to evaluate the efficacy and safety of three treatment options for BPH, a prevalent condition affecting older males. The trial's termination due to recruitment challenges highlights potential market barriers for new BPH therapies. The competitive landscape includes established treatments and emerging minimally invasive options. Companies such as Urologix and Medtronic are key players in this space, indicating a need for innovative approaches to enhance patient recruitment and engagement in clinical trials. The findings could influence market strategies for existing and future BPH therapies.

Matched by modality_normalized: medical device

Stability Effects After Heel Cups Orthopedics Treatment in Different BMI Index and Its Correlation to Physical Activity in Children. A Longitudinal Intervention Study

The study, sponsored by Universidad Miguel Hernandez de Elche, investigates the impact of heel cups on postural stability in children aged 8-12 with varying BMI. Given the rising prevalence of childhood obesity and associated musculoskeletal disorders, this research addresses a significant public health concern. If successful, the findings could support the commercialization of heel cups as a preventive and therapeutic intervention in pediatric populations, potentially leading to partnerships with orthopedic device manufacturers. The absence of existing evidence on the stability effects of heel cups presents a competitive opportunity for differentiation in the pediatric orthopedic market. Stakeholders should consider the implications of these findings for product development and marketing strategies targeting both healthcare providers and parents.

High-Definition Transcranial Direct Current Stimulation (HD-tDCS) in Amyotrophic Lateral Sclerosis: A Multicenter Randomized Controlled Trial

The multicenter randomized controlled trial aims to evaluate the efficacy of HD-tDCS in patients with Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease with significant unmet medical needs. The trial's focus on respiratory function and disease progression positions it strategically within the ALS treatment landscape, which currently lacks effective therapies. If successful, this intervention could provide a novel non-invasive treatment option, potentially capturing market share in a niche but critical segment of neuromodulation therapies. The trial is sponsored by Universidade Federal do Rio Grande do Norte, indicating a strong academic backing, which may enhance credibility and attract future partnerships or funding opportunities. Competitive implications include the need to monitor other neuromodulation approaches and therapies targeting ALS, as well as the broader market for neurostimulation devices.